What are the challenges of commercialization of health management in China?

from the report of the Chinese and U.Smarket in the development group health management model of the conditions of the analysis, can be summarized to summarize the causes of these differences, the main reasons are China's health care model and payment environment and the United States is completely differentChina's payers have a weak influence on the medical service side, even if the health care, the management of the service side is extensive, commercial insurance is not able to affect the core part of the serviceThis means that China's commercial insurance can not through service price negotiation, screening quality of service to establish their own effective service networkThe all-inclusive nature of China's large hospitals means that the industrial chain is very short and does not require insurance companies to connect professional resourcesThis has led to the purchase of health management services by Chinese insurance companies mainly concentrated in the light medical examination, referral and Greenpass services, not in-depthdata consistency collection and analytical methods are scarce in the Chinese marketFrom the point of view of the intervention effect of chronic disease management, the error compared with historical data will be greater, because China's chronic disease education and preventive measures are missing, there are many patients who did not know their illness in the past, and the measures they have been detected after the disease may quickly improve their indicators, in this case, the slow disease management project after implementation and pre-implementation comparison is not reasonabletherefore, more effective evaluation of chronic disease management effectiveness in the future should be more rigorous, through the experimental group and non-experimental group of the control, showing the role of chronic disease management in users who already know the diseaseAt the same time, the evaluation indicator sits not only by examining the change of the indicator, because after all, treatment is related to many comprehensive factors, and the patient's own condition and health is closely related, so it can be combined with more intuitive factors such as weight for comprehensive assessmentserious clinical assessment satouts will be more difficult to implement in the public hospital system, which is the main reason why chronic disease management projects in most markets are unable to provide effective data to prove their effectivenesschina and the United States face the same dilemma, that is, they cannot rely on doctors for health management services, even in Taiwan and JapanTherefore, commercial insurance in the United States established a nurse team as the core of the health management service model, relying on nurses to call for health tracking, health resources convergence and case managementChina's insurance companies lack the right staff to lead and provide health management servicesChina's nurses in both professional strength and management capacity and foreign countries have a large gapSecond, China's group insurance companies in the enterprise medical insurance supplementary insurance profit is very low, products are the same, the market competition is fierce, lack of profit balance to do manpower-intensive servicesChina's limited corporate insurance coverage, on the basis of medical insurance to provide limited protection This is different from countries like The UK, where universal health care is available Although the same universal health insurance country, the UK's group insurance is improved by the coverage and quality of service (upgrade to private hospitals, avoid queues, get better services) And China's group insurance is only on the basis of staff health insurance, to improve part of the degree of protection, and the scope of promotion is limited, but it is difficult to improve the quality of service, because under the limited premium, can not cover the cost of VIP services in public hospitals Therefore, under such limited protection, it is difficult for China's group insurance to come up with more costs to carry out the real health management online parts of China's group health management business are hard to come by Because it cannot affect the behavior of doctors, online medical services remain in the consultation stage, which is very different from the U.S telemedicine into commercial insurance reimbursement coverage Therefore, the actual effect of this part of the service on the staff is very limited (original title: Challenges to commercialization of health management in China)